Search
MUC1 Dendritic Cell Vaccine
go.drugbank.com/drugs/DB05477InvestigationalThese cells are then given back to a patient as a vaccine in order to allow for a potent immune response to cancer.
Menatetrenone
go.drugbank.com/drugs/DB12148InvestigationalMenatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma.
Categories: Drugs for Treatment of Bone DiseasesNiflumic acid
go.drugbank.com/drugs/DB04552InvestigationalNiflumic acid is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Categories: Topical Products for Joint and Muscular Pain, Antiinflammatory Preparations, Non-Steroids for Topical UseMBO7133
go.drugbank.com/drugs/DB04999ExperimentalHowever, araC is only slowly converted to araCTP in the liver or in primary liver tumors due to low levels of an enzyme in the liver that is required for the conversion of araC to araCMP, the first step
Basic Fibroblast Growth Factor
go.drugbank.com/drugs/DB14131InvestigationalAlthough it is not approved for use in Canada or the USA, bFGF is currently undergoing investigation in a number of clinical trials.
Nizofenone
go.drugbank.com/drugs/DB13546ExperimentalCategories: Psychostimulants, Agents Used for ADHD and NootropicsAlgestone
go.drugbank.com/drugs/DB18000ExperimentalCategories: Hormonal Contraceptives for Systemic UseIMM-101
go.drugbank.com/drugs/DB15850InvestigationalIt has shown to be safe and well tolerated to complement conventional cancer therapy for patients with melanoma and pancreatic ductal adenocarcinoma[A220013,A220018,A220023].
Rocatinlimab
go.drugbank.com/drugs/DB18809InvestigationalRocatinlimab is a subcutaneously administered anti-OX40 antibody developed for the treatment of moderate-to-severe atopic dermatitis.
4-Hydroxytestosterone
go.drugbank.com/drugs/DB01485IllicitInvestigational[A14385] Like formestane, 4-hydroxytesterone has been patented for use in decreasing estrogen production in the body, but no such indication currently exists. 4-Hydroxytestosterone was first patented in